100% Natural
Lipid Regulator

What is Lipascor® ?

Lipascor® is an all natural product for use in the management of healthy blood lipid (cholesterol) levels.

It contains the original proprietary ingredient, xuezhikang®, derived through extensive research and development of the fermentation of red yeast (Monascus purpureus Went species) on premium rice.

  • Clinically Proven
  • Safe and Effective Lipid Management Option

Why choose Lipascor® ?

  • Lipascor® is regulated by Health Sciences Authority (HSA) and certified Chinese Proprietary Medicine (CPM) in Singapore since 2001
  • Lipascor® complies to safety and quality parameters of HSA for toxic heavy metals limit and microbial contamination
  • Every batch of Lipascor® is standardised and tested to ensure consistency in its active ingredients.
  • Lipascor® is well supported by clinical evidence of its safety and efficacy

"Randomized placebo controlled study showed that xuezhikang® effectively improved preprandial and postprandial endothelial function through its potent anti-inflammatory and lipid-lowering effects"

Circulation 2004;110:915-920 Journal of The American Heart Association

Details

Active ingredients

Each Lipascor® capsule contains the proprietary ingredient xuezhikang® 600mg, including by-product of fermentation process consisting of Monacolin K (naturally occurring HMG-CoA reductase inhibitors 0.8%), natural pigment and unsaturated fatty acids.

Lipascor® for individuals with high blood lipid levels

Maintaining a sensible diet and exercise programme should be the first option to achieve healthy blood lipid (cholesterol) levels. Lipascor® is recommended for individuals who have tried and failed to achieve healthy blood lipid (cholesterol) levels through diet and exercise, as well as patients who are not willing or unable to tolerate conventional statin treatment.

Lipascor® mode of action

Naturally occurring Monacolin (HMG-CoA reductase inhibitors) found in Lipascor® capsules reduce the amount of lipids produced by the liver resulting in the effective regulation of circulating blood lipid (cholesterol and triglyceride) levels.

Lipascor® (xuezhikang®) is Characterised and Standardised RYR

Lipascor® (xuezhikang®) contains 600mg standardised Red Yeast Rice (RYR) extract concentrate

Every batch of Lipascor® (xuezhikang®) is standardised and tested to ensure consistency in its active ingredients as regulated by Health Sciences Authority (HSA)

Prescribing Information

Description

Lipascor® capsule contains the proprietary ingredient xuezhikang®, an all-natural product scientifically derived from fermentation of red yeast (Monascus purpureus Went species) on premium rice.

Active Ingredient

Each Lipascor® capsule contains the proprietary ingredient xuezhikang® 600mg, which is 600mg standardised Red Yeast Rice extract concentrate derived from fermentation of Monascus purpureus Went species on premium rice, including by-product of fermentation process consisting of Monacolins K (naturally occurring HMG-CoA reductase inhibitors 0.8%), natural pigment and unsaturated fatty acids.

Indication

For reducing elevated levels of serum lipid levels in patients with primary dyslipidaemia.

Dosage

One capsule twice daily after meals (morning and evening).

Storage

  • Store in a cool dry place, away from excessive heat and light
  • Keep out of reach of children

Presentation

Lipascor® is a Chinese Proprietary Medicine. Each box supplies 60 Lipascor® capsules each containing 600mg xuezhikang® in blister packs of 10’s.

Shelf-life

Refer to manufacturing date and expiry date printed on packaging.

Cautions

Consult your doctor for optimal lipid management

Lipid disorder is part of a complex metabolic syndrome that increases the risk of cardiovascular disease. Consult your doctor for overall risk management.

  • Patients who are pregnant, intend to be pregnant or breast feeding should not take Lipascor® capsule
  • Lipascor® capsule is not recommended for patients under 20 years of age
  • Lipascor® capsule is not recommended for patients at risk for or having history of liver diseases
  • Lipascor® capsule should be avoided in patients who consume more than 2 drinks of alcohol per day; have a serious infection; have undergone organ transplant; have serious disease or physical disorder or have undergone a major surgery recently
  • Patients on long-term use of Lipascor® capsule are advised to test for Alanine Aminotransferase (ALT) and Creatine Kinase (CK) periodically at medical clinics
  • Lipascor® capsule may cause mild gastrointestinal upset that can be alleviated if the product is taken after meals. Patients need not cease administration of Lipascor® capsule if suffering from minor gastrointestinal upset
  • Co-administration of cyclosporin, fibric acid derivatives, niacin (nicotinic acid), erythromycin and azole antifungals should be avoided
  • Lipascor® capsule should not be taken with grapefruit juice

Abstracts and Full Clinical Papers

COMPLETE STUDY OF

Pivotal Study on Safety and Efficacy
Efficacy and Safety
Comparative Studies
Studies in Fatty Liver Patients
Studies in NIDDM
Studies in Hypertention
Studies in Inflammation
Studies in Geriatric
Studies in Patients With Microcirculation Problems
Studies in Kidney Dialysis Patients
Pre-Clinical Toxicology and Other Studies

© 2015 Luye Pharma (Singapore) Pte Ltd. All rights reserved.

Notices and Legal Disclaimer

Information on this web site is provided for informational purposes only and is not a substitute for professional medical advice. You should not use the information on this web site for diagnosing or treating a medical or health condition. You should carefully read all product packaging. If you have or suspect you have a medical problem, promptly contact your professional healthcare provider.

Statements and information regarding dietary supplements have not been evaluated or approved by the U.S. Food and Drug Administration. Please consult your healthcare provider before beginning any course of supplementation or treatment.

Contact

Working with Nature for Good Health

  • This field is required
  • This field is required
  • This field is required

Manufactured by:
Beacons Pharmaceuticals Pte Ltd
21 Chin Bee Avenue
Singapore 619942

Manufactured for:
Luye Pharma (Singapore) Pte Ltd
(a wholly owned subsidiary of Luye Pharma Group Ltd.)
137 Telok Ayer Street #05-05, Singapore 068602
Tel: (65) 6220 0119 Fax: (65) 6220 0282

Distributed and Marketed by:
Steward Cross Pte Ltd
801, Lorong 7 Toa Payoh, #06-06 Wearnes Building
Singapore 319319
Order Line: (65) 6253 2938, (65) 6250 6778
Fax: (65) 6253 2438